Related Experiment Video
Updated: Feb 1, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
[Colorectal cancer surgery in the elderly]
Alexia Patroni1, David Moszkowicz1, Dominique Morle2
1AP-HP, Service de chirurgie digestive, oncologique et métabolique, Hôpital Ambroise-Paré, 9 avenue Charles-de-Gaulle, 92104 Boulogne-Billancourt cedex, France; Université de Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, UFR des sciences de la santé Simone-Veil, 2 avenue de la Source-de-la-Bièvre, 78180 Montigny-Le-Bretonneux, France.
Colorectal cancer surgery in elderly patients carries higher risks. Early postoperative rehabilitation is crucial for improving outcomes in this vulnerable population.
Area of Science:
- Oncology
- Geriatric Medicine
- Surgical Outcomes
Background:
- Colorectal cancer (CRC) risk increases with age and comorbidities.
- Factors like delayed diagnosis and frailty complicate CRC management.
- CRC surgery is standard, with survival rates comparable to younger patients.
Purpose of the Study:
- To evaluate the risks associated with colorectal cancer surgery in the elderly.
- To emphasize the importance of postoperative care strategies for older adults.
Main Methods:
- Analysis of outcomes for elderly patients undergoing colorectal cancer surgery.
- Review of factors contributing to morbidity and mortality.
Main Results:
- Elderly patients face increased morbidity and mortality from colorectal cancer surgery.
- Age, comorbidities, and frailty are significant risk factors.
Conclusions:
- Colorectal cancer surgery in the elderly is associated with excess risks.
- Early postoperative rehabilitation is recommended to mitigate these risks and improve patient recovery.
Related Concept Videos
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

